Perioperative Complications in Minimally Invasive Sacrocolpopexy Versus Transvaginal Mesh in the Management of Pelvic Organ Prolapse: Analysis of a National Multi-institutional Dataset

• Published in: Female pelvic medicine & reconstructive surgery Vol. 27; no. 2; p. 72
• Main Authors: Kisby, Cassandra K, Occhino, John A, Bews, Katherine A, Habermann, Elizabeth B, Linder, Brian J
• Format: Journal Article
• Language: English
• Published: United States 01.02.2021
• Subjects: Blood Transfusion - statistics & numerical data; Cohort Studies; Datasets as Topic; Female; Gynecologic Surgical Procedures - adverse effects; Gynecologic Surgical Procedures - methods; Humans; Laparoscopy; Length of Stay - statistics & numerical data; Middle Aged; Patient Readmission - statistics & numerical data; Pelvic Organ Prolapse - surgery; Postoperative Complications; Reoperation - statistics & numerical data; Retrospective Studies; Surgical Mesh - adverse effects; Urinary Tract Infections - etiology
• ISSN: 2154-4212
• DOI: 10.1097/SPV.0000000000000738

The objective of this study was to evaluate perioperative complications in women who underwent minimally invasive sacrocolpopexy (MISC) versus mesh-augmented vaginal repair (vaginal mesh) for pelvic organ prolapse. We identified patients undergoing MISC and vaginal mesh via Current Procedural Terminology codes from the American College of Surgeons National Surgical Quality Improvement Program database from 2005 to 2016. Those undergoing concomitant hysterectomy were excluded. Univariate analyses were performed to compare baseline characteristics and 30-day complications. Multivariable logistic regression models were constructed to assess the association between surgical approach and complications, prolonged hospitalization, reoperation, and blood transfusion. A multivariable Cox proportional hazard model was used to evaluate hospital readmission. A total of 5722 patients were identified (2573 MISC [45%], 3149 vaginal mesh [55%]). Those undergoing MISC repairs had a significantly lower rate of urinary tract infection (3.1 vs 4.2%; P = 0.03) and blood transfusion (0.5 vs 1.4%; P < 0.001). There was no difference in reoperation rate (1.3 vs 1.6%; P = 0.35). Multivariable analysis showed no significant association of MISC with overall (odds ratio [OR], 0.91; P = 0.44), major (OR, 1.30; P = 0.31), or minor complication (OR, 0.85; P = 0.26). There were lower odds of receiving a blood transfusion (OR, 0.44; P = 0.02) and higher odds of prolonged hospitalization (>2 days; OR, 1.47; P = 0.003) for the MISC group. There was no difference in reoperation (OR, 0.79; P = 0.38) or hospital readmissions (hazard ratio, 1.25, P = 0.32). Minimally invasive sacrocolpopexy was associated with a lower rate of blood transfusion than transvaginal mesh placement. There was no significant difference in 30-day complication rates, reoperation, or readmission between these prolapse procedures when performed without concomitant hysterectomy.